A hallmark of our PPG is the development of quantitative techniques to gain insight into physiological processes limiting the effective use of therapeutic agents. The primary scientific focus of this core involves three fields related by their bioengineering emphasis: intravital microscopy, mathematical modeling, and image analysis. Two other important functions of this core are:maintenance of computer systems and biostatistical guidance in experimental design and data interpretation. Each project relies on microscopy to quantify physiological and biophysical parameters. The core will therefore continue to pioneer new quantitative methods (e.g. in vivo multiphoton fluorescence correlation spectroscopy), continuing a long- standing tradition recently confirmed by three papers published in the New Technology section of Nature Medicine (2001,2003, 2004, 2005). The bioengineering core will also acquire and maintain optical equipment, and related electronic and photographic equipment for recording and analyzing images. Core leaders will instruct and assist researchers in the use of microscopy techniques and related image analysis software. Mathematical modeling will be used to help understand transport barriers on several length scales and for a variety of therapeutic agents. Whole body, organ, microscopic, and in vitro models have been developed and used successfully by the lab. In the proposed PPG this aspect of the bioengineering core will be essential in interpreting data in all projects, e.g. for analyzing vascular permeability data, interstitial flow and transvascular transport studies. Image analysis requires the collection, analysis, and visualization ofcomplex data obtained in all projects. As this involves considerable knowledge of software and hardware systems, this important need is best served with a core facility. Likewise, the maintenance of computer hardware, software, and networks is best performed with a knowledgeable computer systems manager. Finally, the quantitative aspects of our research methods require close collaboration with a biostatistician in all phases of the research: experimental design (protocols and animal calculations), analysis of experimental data, and careful estimation of model parameters with nonlinear regression techniques. The three research projects in this PPG could not be carried out if the services of the bioengineering core component were not available.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA080124-09
Application #
7874642
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
9
Fiscal Year
2009
Total Cost
$241,985
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Ina Ly, K; Vakulenko-Lagun, Bella; Emblem, Kyrre E et al. (2018) Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI. Sci Rep 8:17062
Nowak-Sliwinska, Patrycja; Alitalo, Kari; Allen, Elizabeth et al. (2018) Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis 21:425-532
Zhao, Yingchao; Liu, Pinan; Zhang, Na et al. (2018) Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models. Proc Natl Acad Sci U S A 115:E2077-E2084
Hong, Theodore S; Grassberger, Clemens; Yeap, Beow Y et al. (2018) Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy. NPJ Precis Oncol 2:22
Pinter, Matthias; Kwanten, Wilhelmus J; Jain, Rakesh K (2018) Renin-Angiotensin System Inhibitors to Mitigate Cancer Treatment-Related Adverse Events. Clin Cancer Res 24:3803-3812
Arvanitis, Costas D; Askoxylakis, Vasileios; Guo, Yutong et al. (2018) Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption. Proc Natl Acad Sci U S A 115:E8717-E8726
Khandekar, Melin J; Jain, Rakesh (2018) Smooth sailing for immunotherapy for unresectable stage III non-small cell lung cancer: the PACIFIC study. Transl Cancer Res 7:S16-S20
Stylianopoulos, Triantafyllos; Munn, Lance L; Jain, Rakesh K (2018) Reengineering the Tumor Vasculature: Improving Drug Delivery and Efficacy. Trends Cancer 4:258-259
Grassberger, Clemens; Hong, Theodore S; Hato, Tai et al. (2018) Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer. Int J Radiat Oncol Biol Phys 101:1222-1225
Zhang, Na; Chen, Jie; Ferraro, Gino B et al. (2018) Anti-VEGF treatment improves neurological function in tumors of the nervous system. Exp Neurol 299:326-333

Showing the most recent 10 out of 320 publications